quinoxalines has been researched along with trypan blue in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DW; Regan, RF | 1 |
| Beirith, A; Calixto, JB; Santos, AR | 1 |
| Bradley, SJ; Coopman, K; Huang, Y; Johnston, N; Wilkinson, GF; Willars, GB | 1 |
3 other study(ies) available for quinoxalines and trypan blue
| Article | Year |
|---|---|
The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium Channel Blockers; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; L-Lactate Dehydrogenase; Mice; Neuroglia; Neurons; Nimodipine; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Trypan Blue | 1994 |
Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw.
Topics: Animals; Azo Compounds; Coloring Agents; Dizocilpine Maleate; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extremities; Glutamic Acid; Glutamine; Male; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitroarginine; Nociceptors; Penicillamine; Quinoxalines; Trypan Blue | 2002 |
Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.
Topics: Biotransformation; Calcium; Cell Line; Cell Membrane; Cell Survival; Cyclic AMP; Data Interpretation, Statistical; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Green Fluorescent Proteins; GTP-Binding Proteins; Humans; Ligands; Peptide Fragments; Quinoxalines; Receptors, Glucagon; Signal Transduction; Sulfones; Trypan Blue | 2010 |